REG - Pharma C Investments - Pharma C Invests in Product Earth Expo

Walt Disney CoAnnouncement

08/11/2021 08:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211108:nRSH5730Ra&default-theme=true

RNS Number : 5730R  Pharma C Investments PLC  08 November 2021

08 November 2021

Pharma C Investments Plc

("Pharma C" or the "Company")

Pharma C Invests in Product Earth Expo

 

Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder
in the medical cannabis industry with a particular focus on ancillary
businesses, is pleased to announce that it has completed its first investment
in a company called Product Earth Expo UK Limited ("Product Earth").

 

Product Earth is the UK's leading hemp and CBD trade show and exposition
("expo"). The event showcases cannabis-related businesses from the
agricultural, industrial and medicinal, to production, wholesale and retail
sectors. Product Earth also offers its customers a bespoke digital marketing
service, providing support and expertise in showcasing their companies to a
growing audience.

 

Highlights

 

·      Pharma C is investing £275,000 for 7.5% of the enlarged share
capital of Product Earth, valuing Product Earth at £3.68m

·      Product Earth held its first event in 2015 and despite the ban on
public events in 2020, hosted a successful, profitable event in August 2021 at
the National Agricultural Exhibition Centre

·      In response to the pandemic, Product Earth built a digital
marketing agency for hemp and cannabis-related businesses

·      Product Earth is led by entrepreneurs with deep expertise in
cannabis, media, and technology

·      Product Earth has the ability and scope to expand its events and
services into Europe and beyond

Product Earth supported the COP26 fringe event, Beyond the Green, in Glasgow
which ran from 5(th) - 7(th) November. The event promoted the need to put the
use of hemp high up on the climate agenda, due to its potential to decarbonise
multiple industries and combat climate change through carbon capture. The
event also looked at the medicinal benefits, job creation and health benefits
the cannabis plant can provide.

 

Find out more at www.productearthexpo.com/ (http://www.productearthexpo.com/)

Sharon Segal, Chair of Pharma C Investments, said: "This is a major first step
for Pharma C. The Board has considered a number of investment opportunities
since admission to AQSE in May and we are delighted to welcome Product Earth
as our first investee company. This investment exemplifies our focus on the
non-plant touching, ancillary sector which support the growth of the medical
cannabis industry.

"Product Earth has a special place in the UK cannabis industry as the first
medical cannabis, CBD and hemp trade show. Product Earth has also developed
digital marketing capabilities to support clients with broader brand building;
its high-quality management team has decades of experience from the likes of
Facebook and Yahoo. We look forward to working alongside the Product Earth
team to support the business as it builds upon its foundations and looks
towards global expansion."

Tom Toumazis, MBE, Chair of Product Earth, said: "Product Earth is entering an
exciting chapter as we service a rapidly growing sector in the UK. Hosting an
event in 2021 came with its challenges but we still managed to make it a
successful and profitable experience. Our digital marketing service is
unrivalled within the cannabis industry, and we are proud to be helping
exciting and interesting businesses grow.

"I am looking forward to working with Pharma C and utilising the expertise
provided by the Board and management team. At Product Earth, we are committed
to providing a world-class event for our customers and their clients, as well
as expanding our digital marketing service to offer a range of products for a
growing audience. Product Earth is also looking at taking its event to more
countries around the world, enabling customers, businesses, patients and
experts to connect on a global scale."

Related Party Transaction

Gavin Sathianathan, Investment Strategy Director of Pharma C, is a director
and shareholder of Product Earth and the investment is therefore a related
party transaction in accordance with Rule 4.6 of the AQSE Growth Market Access
Rulebook.

Company update

As at 31 October 2021, Pharma C had cash balances of £607,870.

 

The Directors of Pharma C Investments plc take responsibility for this
announcement.

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended).

 

- Ends -

 

 Pharma C Investments       Tel: +44 207 138 3204
                            Sharon Segal, Chair            sharon@pharmacinvestments.com

 Novum Securities           Tel: +44 207 399 9429

 (AQSE Corporate Adviser)
                            David Coffman / Lucy Bowden

 Blytheweigh                Tel: +44 207 138 3204

 (Financial PR/IR-London)
                            Tim Blythe                     tim.blythe@blytheweigh.com (mailto:tim.blythe@blytheweigh.com)
                            Megan Ray                      megan.ray@blytheweigh.com (mailto:megan.ray@blytheweigh.com)

 

About Pharma C Investments

Pharma C Investments is an investment vehicle targeting the legal medicinal
cannabis industry globally. The Company is seeking to identify breakout
companies within the legal markets with a particular focus on the UK, EU and
Israel and will provide capital, strategic insights and operational support.
Pharma C is run by cannabis entrepreneurs who understand the unique challenges
of the legal cannabis industry and thus can provide invaluable support and
expertise for growing companies.

About Product Earth

Product Earth is the UK's leading hemp and CBD trade show and expo. The event
showcases businesses from agricultural, industrial and medicinal, to
production, wholesale and retail. The annual event is based outside Coventry
at the National Agricultural Exhibition Centre (NAEC), welcoming the emerging
hemp and cannabis industry into the fold of mainstream agriculture.

The Company is driven by a team of industry leaders including Tom Toumazis,
MBE, Chairman, and Matthew Clifton, Chief Executive Officer. Tom is a renowned
portfolio director, investor and adviser, focused on technology, media and the
arts, with experience at companies such as ITV, Eurosport and Disney. Matthew
Clifton was an early employee of Facebook, working with the Company as Head of
Business Product Marketing for EMEA before transitioning into the cannabis
sector. Matthew was one of the first six UK employees of Facebook, driving the
product marketing division focusing on the small and medium businesses and
advertising to grow the businesses through the community.

Due to the impact of Covid-19 related lockdowns, the event industry came to a
halt in 2020. In response, Product Earth pivoted business strategy and
utilised its Board's expertise in the technology space to provide a digital
marketing service for wellness and cannabis-related businesses. This business
proved to be an invaluable tool for Product Earth's customers, allowing them
to connect with audiences and showcase their innovative and exciting products
and services, using the data gathered over the last five years.

Product Earth has the unique opportunity to capitalise on its first mover
advantage in the UK. The Company also has the ability and scope to expand its
events into Europe and further afield.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXUPGWCGUPGGBM